How much does Custom Pharmaceuticals Limited make?

Custom Pharmaceuticals Limited reported revenue of £16.7m and £252k profit in the year to 30 Jun 2025, according to its accounts filed at Companies House.

How many employees does Custom Pharmaceuticals Limited have?

Custom Pharmaceuticals Limited reported an average of 142 employees in the year to 30 Jun 2025.

Is Custom Pharmaceuticals Limited profitable?

Yes — Custom Pharmaceuticals Limited reported a profit of £252k in the year to 30 Jun 2025.

Company No. 01431692 · Incorporated 20 Jun 1979

Custom Pharmaceuticals Limited

Registered name: CUSTOM PHARMACEUTICALS LIMITED

Part of Cheremy Capital Llc group

Custom Pharmaceuticals Limited made £16.7m revenue and £252k profit in the year to 30 Jun 2025.

Custom Pharmaceuticals Limited’s revenue was £16.7m in the year to 30 Jun 2025, with £252k profit and 142 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in Hove; we hold 3 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21200Manufacture of pharmaceutical preparations

Status: Voluntary Arrangement
Location: Hove, South East
Age: 47 yrs · since 1979
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Jun 2025

Key figures

Revenue

£16.7m

Growth —

Profit

£252k

Growth —

Profit margin

1.5%

Gross 22.2%

Employees

142

Change —

Profit / employee

£1.8k

Revenue/employee £117k

Profitable streak

1yr

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	30 Jun 2024	30 Jun 2025
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£14.1m	£23.7m	£16.7m
Cost of sales	£12.7m	£22.6m	£13m
Gross profit	£1.4m	£1.2m	£3.7m
Operating profit	£112k	−£4m	£400k
Profit before tax	−£2.6k	−£5.1m	£252k
Profit after tax	£176k	−£5m	£252k
Profit (best available)	£176k	−£5m	£252k
Staff costs	£6.9m	£10.7m	£6.1m
Employees (average)	198	179	142
Ratios
Profit margin	1.3%	−20.9%	1.5%
Gross margin	9.9%	4.9%	22.2%
Revenue per employee	£71.3k	£133k	£117k
Profit per employee	£889	−£27.7k	£1.8k
Balance sheet — indirect signals, not revenue
Cash at bank	£558k	£158k	£655k
Net assets	£7.1m	£2.1m	£2.4m
Fixed assets	£6.6m	£5.1m	£4.5m
Current assets	£6.3m	£6.7m	£7.5m
Debtors	£2m	£2.3m	£2.9m
Deferred income	£189k	£23.1k	£0
Source	FullAccounts · bulk data Mar 2025	FullAccounts · bulk data Mar 2025	FullAccounts · bulk data Feb 2026

Derived from the latest filing

How the business works

Profit margin: 1.5%; Profit ÷ revenue.
Gross margin: 22.2%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £117k; Revenue ÷ average employees.
Profit per employee: £1.8k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 26.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 0%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 17.2%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now £2.4m
Cash at bank: —; Now £655k
Headcount: —; Now 142
Deferred income: —; Now £0
Fixed assets: —; Now £4.5m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Cheremy Capital Llc (registered outside the UK register)ultimate parent75–100%
Custom Pharmaceuticals Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Jun 2025 (profit £252k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.